DNAJB1 and fibrolamellar hepatocellular carcinoma: •A unique genetic alteration drives the pathogenesis of fibrolamellar carcinoma (DNAJB1-PRKCA fusion) and hepatic haemangioendothelioma (CAMTA1-WWTR1 fusion).